News | January 20, 2023
Blue Jet Healthcare gets SEBI nod for IPO
The company will not receive any proceeds from the offer as all of it will go to the promoter selling shareholder.
The company will not receive any proceeds from the offer as all of it will go to the promoter selling shareholder.
The company is one of the most profitable companies manufacturing speciality chemicals in India
The IPO is a complete OFS by existing shareholder Helix Investment Holdings
The product is expected to be launched by Q4 FY23.
ANI’s Clorazepate Dipotassium Tablets are the generic version of the Reference Listed Drug (RLD) Tranxene.
Glenmark's current portfolio consists of 174 products authorized for distribution in the U.S. marketplace and 48 ANDA's pending approval with the USFDA
MilliporeSigma to become the first company to offer a fully integrated ecosystem for advanced process technologies
It is only the second generic application approved by the USFDA
Divalproex Sodium Extended-Release tablets are indicated for the treatment of acute manic or mixed episodes associated with bipolar disorder, as monotherapy and adjunctive therapy and prophylaxis of migraine headaches
The companies plan to use the proceeds to retire debt and expand operations
Subscribe To Our Newsletter & Stay Updated
